Mark Mallon
Overview
Mark Mallon received an average of $6M in total compensation, including $572K in salary, at Ironwood Pharmaceuticals from 2019 to 2021.
Source: SEC filings on April 21, 2022, April 22, 2021, and April 21, 2020.
Related executives
We found 12 more executives who work or worked at Ironwood Pharmaceuticals.
Thomas McCourt
Ironwood Pharmaceuticals
Chief Executive Officer
Jason Rickard
Ironwood Pharmaceuticals
Chief Operating Officer
John Minardo
Ironwood Pharmaceuticals
Chief Legal Officer
Gina Consylman
Ironwood Pharmaceuticals
Chief Financial Officer
Michael Shetzline
Ironwood Pharmaceuticals
Chief Medical Officer
Sravan Emany
Ironwood Pharmaceuticals
Chief Financial Officer
Peter Hecht
Ironwood Pharmaceuticals
Chief Executive Officer
Mark Currie
Ironwood Pharmaceuticals